Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1992-8-31
pubmed:abstractText
1. The effects of metabotropic glutamate receptor agonists on excitatory synaptic transmission in the CA1 region of rat hippocampal slices (11-30 days) were studied using extracellular and whole-cell patch-clamp recording techniques. 2. Trans-1-amino-1,3-cyclopentanedicarboxylic acid (trans-ACPD; 25-100 microM) reversibly depressed excitatory postsynaptic currents (EPSCs) without affecting presynaptic fibre excitability or EPSC reversal potential. 3. Ibotenate (25 microM) or L-glutamate (250 microM), in the presence of the N-methyl-D-aspartate (NMDA) receptor antagonist, D-2-amino-5-phosphonovaleric acid (APV, 50-75 microM), depressed the EPSC amplitude while inducing no detectable inward current. L-2-Amino-4-phosphonobutyrate (L-AP4, 25-100 microM), the phosphonic derivative of glutamate, also depressed EPSC amplitude and caused no detectable inward current. 4. The NMDA receptor-mediated component of the EPSC recorded in the presence of the non-NMDA receptor antagonist, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, 20-30 microM) was depressed by trans-ACPD, L-AP4, or quisqualate (1-2 microM). 5. The response to ionophoretic application of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) was unaffected by trans-ACPD or L-AP4 although the simultaneously recorded EPSC was strongly depressed. In addition, paired-pulse facilitation (50-75 ms interstimulus interval) was reversibly enhanced by trans-ACPD or L-AP4. These results indicate that the depression of synaptic transmission likely was mediated by a presynaptic 'autoreceptor'. 6. The effects of trans-ACPD or L-AP4 on synaptic transmission decreased significantly over ages 12-30 days and were minimal in adult (greater than 80 days) slices. 7. The depression of synaptic transmission caused by trans-ACPD or L-AP4 was not altered following the induction of long-term potentiation (LTP). 8. The results indicate that metabotropic glutamate receptor agonists suppress excitatory synaptic transmission in CA1 pyramidal cells by an action at a presynaptic site. This effect is developmentally regulated and is maximally expressed during the first postnatal month.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-13278890, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-1646727, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-1671527, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-1964256, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-1964257, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-1971515, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-1972190, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-1975659, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-209851, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-2153480, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-2164158, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-2167454, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-2172830, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-2177502, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-2200979, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-2537984, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-2543272, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-2553440, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-2558391, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-2576231, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-2607782, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-2834517, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-2845577, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-2865680, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-2869493, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-2875763, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-2880300, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-2890405, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-2906296, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-2918347, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-3795109, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-6123949, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-6145492, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-6266585, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-6317423, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-7171996, http://linkedlifedata.com/resource/pubmed/commentcorrection/1668353-7278366
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0022-3751
pubmed:author
pubmed:issnType
Print
pubmed:volume
444
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
687-701
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1991
pubmed:articleTitle
Agonists at metabotropic glutamate receptors presynaptically inhibit EPSCs in neonatal rat hippocampus.
pubmed:affiliation
Department of Psychiatry, University of California, San Francisco 94143.
pubmed:publicationType
Journal Article, In Vitro, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't